Efficacy of Praziquantel against Schistosoma mekongi and Opisthorchis viverrini: A Randomized, Single-Blinded Dose-Comparison Trial (original) (raw)
Figure 2
Cumulative prevalence according to the sampling effort.
Cumulative infection prevalences for (a) S. mekongi and (b) O. viverrini by the number over consecutive days of stool specimen collection (x-axis). Each point on a curve represents a cumulative prevalence value for each sampling effort (number of Kato-Katz thick smears per stool specimen). At baseline (day 0), n = 90; after treatment (days 28–30), n = 66.